Results 91 to 100 of about 29,554 (155)

Antígenos del sistema sanguíneo ABO como factor de riesgo para la gravedad de la infección por SARS-CoV-2

Gaceta Médica de México, 2021
Carmen G. Torres-Alarcón, Antonio García-Ruíz, Cesar R. Cañete-Ibáñez, Irving I. Morales-Pogoda, Carlos M. Muñoz-Arce, Blanca E. Cid-Domínguez, Maribel Montalvo-Bárcenas, Guadalupe Maza-de la Torre, Chantal Sandoval-López, Emanuel Gaytán-Guzmán, José D. Correo-Zamora   +10 more
doaj   +1 more source

[Strategic independence: a value model for improving access to plasma-derived medicines in Latin AmericaIndependência estratégica: modelo de valor para melhorar o acesso a hemoderivados na América Latina]. [PDF]

Rev Panam Salud Publica
Vahos Zambrano J, Vaca González C, Cortés AY, Bernal DR, Parra Galvis R, von Bonsdorff L.   +5 more
europepmc   +1 more source

¿Qué son y para que se usan los hemoderivados? [PDF]

Sin ...
Viñals Florez, Luis Miguel
core   +1 more source

[Seroprevalence of infectious agents in blood donors and their components]. [PDF]

Rev Med Inst Mex Seguro Soc
Mejía-Aguirre B, Luna-Vargas AK, Benítez-Arvizu G.   +2 more
europepmc   +1 more source

Identification of HIV infection in two solid organ recipients three years after transplantation [PDF]

Biomedica
Mopán NC, Plazas DC, Salinas MA, Arias-Murillo YR, Cortés JA.   +4 more
europepmc   +1 more source

Ten years of the immunogenetics laboratory performance assessment programme and its impact on the donor and transplant network [PDF]

Biomedica
Arias-Murillo YR, Salinas-Nova MA, Toloza-Pérez YG, Castro-Jiménez MÁ.   +3 more
europepmc   +1 more source

[Blood donor infected VHB detected by NAT probable phase in clinical resolution]. [PDF]

Rev Med Inst Mex Seguro Soc
Calderón-Carmona P, Benitez-Arvizu G, Galván-Bobadilla A.   +2 more
europepmc   +1 more source